Constellation Brands
STZ
$166.15
+1.89%
Constellation Brands, Inc. is the largest provider of alcoholic beverages in the United States, operating primarily in the beer, wine, and spirits categories. The company's dominant market position is built on its exclusive rights to import and market top-selling Mexican beer brands, Modelo and Corona, which generate approximately 84% of its revenue, making it a category leader in the high-margin imported beer segment. The current investor narrative centers on the company's ability to sustain growth amid a potential industry-wide slowdown, as evidenced by recent news of a major spirits merger signaling defensive consolidation, while also navigating the performance of its pruned wine and spirits portfolio and its strategic investments, such as its stake in Canopy Growth.…
STZ
Constellation Brands
$166.15
Related headlines
STZ 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Constellation Brands's 12-month outlook, with a consensus price target around $216.00 and implied upside of +30.0% versus the current price.
Average Target
$216.00
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$133 - $216
Analyst target range
Insufficient analyst coverage data is available to form a robust consensus, as the provided data indicates coverage from only one analyst. This limited coverage is atypical for a company of Constellation Brands' size and may indicate a recent change in data sourcing or a period of transition in analyst coverage. The implications are that price discovery may be less efficient and the stock could experience higher volatility due to fewer institutional eyes on the fundamental story. The available data point shows an estimated EPS average of $14.38 for an unspecified period, but without a corresponding target price or a full set of recommendations, a meaningful consensus sentiment, upside calculation, or target range cannot be determined. The recent institutional ratings from firms like Citigroup (upgrade to Buy) and Deutsche Bank (Hold) suggest a mixed but generally positive near-term view, but these are not sufficient to establish a quantitative consensus.
STZ Technical Analysis
The stock is in a sustained uptrend over the medium term, with a 6-month price change of +17.56% and a year-to-date gain of +17.70%, significantly outperforming the broader market. However, it remains in a longer-term corrective phase, trading 10.07% lower over the past year. The current price of $166.15 sits at approximately 66% of its 52-week range ($126.45 to $196.91), indicating it has recovered meaningfully from its lows but remains well below its recent peak, suggesting room for further recovery if momentum persists. Recent short-term momentum is exceptionally strong and diverging positively from the longer-term trend, with the stock up 10.80% over the past month and 13.03% over the past three months, starkly contrasting with the S&P 500's returns of +0.46% and -2.10% over the same periods, respectively. This powerful relative strength suggests the stock is undergoing a significant re-rating or reacting to positive catalysts, potentially marking the early stages of a trend reversal. Key technical levels are the 52-week high of $196.91, representing major resistance, and the 52-week low of $126.45, which serves as critical support. A breakout above resistance would signal a full recovery and potentially new highs, while a breakdown below support would invalidate the recent recovery. The stock's beta of 0.432 indicates it is significantly less volatile than the market, which is unusual for a consumer name but may reflect its defensive cash flows and stable demand profile, implying lower risk for position sizing.
Beta
0.43
0.43x market volatility
Max Drawdown
-34.8%
Largest decline past year
52-Week Range
$126-$197
Price range past year
Annual Return
-10.1%
Cumulative gain past year
| Period | STZ Return | S&P 500 |
|---|---|---|
| 1m | +10.8% | +2.6% |
| 3m | +13.0% | -2.3% |
| 6m | +17.6% | +2.6% |
| 1y | -10.1% | +27.3% |
| ytd | +17.7% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
STZ Fundamental Analysis
Revenue growth has recently turned negative, with Q3 FY2026 revenue of $2.22 billion representing a year-over-year decline of 9.77%. This decline follows a sequential drop from Q2 revenue of $2.48 billion, indicating a deceleration in the top line, likely driven by softer consumer demand or portfolio pruning in the wine and spirits segment. The beer segment, generating $2.01 billion in the latest quarter, remains the core growth driver, while the wine and spirits segment contributed $213 million. The company remains solidly profitable, with Q3 net income of $502.8 million and a net margin of 22.62%. Gross margin for the quarter was healthy at 53.23%, and the trailing twelve-month operating margin stands at 31.33%, demonstrating strong pricing power and brand strength, particularly in its beer portfolio. Profitability has been consistent in recent quarters, excluding a significant loss in Q4 FY2025 related to non-cash impairments. The balance sheet is leveraged but manageable, with a debt-to-equity ratio of 1.31. Financial health is supported by robust cash generation, with trailing twelve-month free cash flow of $1.76 billion, providing ample liquidity to fund dividends, share buybacks, and growth investments. The return on equity of 20.87% is strong, indicating efficient use of shareholder capital. The current ratio of 1.08 suggests adequate, though not excessive, short-term liquidity.
Quarterly Revenue
$2.2B
2025-11
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.53%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is STZ Overvalued?
Given the company's consistent profitability with a positive net income, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The trailing P/E is 16.42x, while the forward P/E is lower at 13.44x, indicating the market expects earnings growth in the coming year. The gap between trailing and forward multiples suggests analysts are forecasting an earnings recovery, aligning with the recent positive price momentum. Compared to sector averages, STZ's trailing P/E of 16.42x appears reasonable for a market leader with strong margins; however, a direct industry average P/E is not provided in the data for a precise premium/discount calculation. Its Price-to-Sales ratio of 3.03x and EV/EBITDA of 11.62x provide additional context for its valuation relative to cash flow and sales. Historically, the stock's own valuation has compressed from higher levels. The current trailing P/E of 16.42x is below the historical P/E of 21.67x from Q3 2024 and significantly below the 28.96x from Q4 2024, indicating the stock is trading at a discount to its own historical average. This positioning near the lower end of its historical valuation band suggests the market has priced in recent growth headwinds, potentially creating a value opportunity if the company's earnings trajectory improves as anticipated.
PE
16.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -21x~6710x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.6x
Enterprise Value Multiple

